Corinne Delcambre

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette et al. · The Lancet Oncology · 2018 · 316 citations

Medicine, Oncology, Pharmacology +13

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

Olivier Mir, Thomas Brodowicz, Antoîne Italiano et al. · The Lancet Oncology · 2016 · 279 citations

Medicine, Oncology, Pharmacology +7

Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)

Patricia Pautier, Anne Floquet, Nicolas Penel et al. · The Oncologist · 2012 · 205 citations · Full text

Medicine, Oncology, Pharmacology +15

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

Isabelle Laure Ray-Coquard, Julien Dômont, Emmanuelle Tresch‐Bruneel et al. · Journal of Clinical Oncology · 2015 · 191 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

Sébastien Salas, Noémie Resseguier, Jean‐Yves Blay et al. · Annals of Oncology · 2017 · 172 citations · Full text

Medicine, Clinical Sciences, Oncology +17